mergers & acquisitions
Avacta Acquires Coris Bioconcept in Deal Potentially Worth £10.4M
Avacta said the deal for Coris is part of an M&A-focused strategy for expanding its diagnostics portfolio and gaining routes into testing markets.
MedGenome Acquires Indian Diagnostics Firm Prognosis Laboratories
Prognosis Laboratories offers services including molecular diagnostics, clinical pathology, hematology, microbiology, serology, immunoassays, and histopathology.
Theralink to Become Subsidiary of IMAC via Stock-for-Stock Reverse Merger
Theralink will become a wholly owned subsidiary of IMAC focused on proteomic testing for guiding cancer therapy and drug development.
Freenome Acquires Cancer Dx Firm Oncimmune
Oncimmune offers its CE-marked EarlyCDT Lung blood test, an autoantibody platform, and a research and development pipeline of more than seven cancer detection signatures.
Transformative Biotech Acquires Summit Biolabs' Direct-to-PCR Technologies
The technology was used during the COVID-19 pandemic to save an estimated 75 percent on lab expenses compared to extraction-based methods.
Feb 17, 2023
EDX Medical Group to Acquire Torax Biosciences
Dec 30, 2022
Top 10 Articles on 360Dx in 2022
Dec 21, 2022